5.900
+13,46%
2026-10-15
Fundamental Analysis
19 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -72.8% | +10.4% | 1 / 3 | -10.7% | -3.64 pp | -3.77 pp | +2.5% | 0.41 | 23.44 | 146 | −10,7% | 2,4 | −72,8% | 23.44 | 7.37 | +218,0% |
| Pts | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 5.900 (close price on 2026-10-15)EPS (TTM): 251,8
Financial charts
1.Revenue & growth
VND bn146Q2/26
1.Revenue & growth
VND bn146Q2/26
2.Profit & growth
VND bn2,40Q2/26
3.Profit mix (Penman)
VND bn6,65Q2/26
4.Margins & cost structure
%9.4%Q2/26
5.Returns & cash cycle
% · days4.8%Q2/26
6.Earnings quality & cash
VND bn39,5Q2/26
7.Asset structure
VND bn469Q2/26
8.Funding & debt health
VND bn · times469Q2/26
9.Revenue backlog
VND bn13,7Q2/26
10.Valuation
times · %23,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %96Q2/26
Adjusted EPS growth, latest quarter
-72.8%
Average adjusted EPS growth, 3 quarters
-60.7%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26